Mr. Dugan leads pharmacy services across a pediatric system spanning four hospitals and 12 specialty clinic and urgent care locations, with accountability for approximately $175 million in annual pharmaceutical spend and $217 million in controllable pharmacy expense. He leads a team of more than 350 pharmacists, technicians and leaders across inpatient, ambulatory, specialty and outpatient services, and oversees investigational drug services, medication safety, prior authorization infrastructure, procurement and 340B program optimization. Over the past five years, Mr. Dugan delivered $5 million to $7 million in annual cost savings through group purchasing organization optimization, contract renegotiations, therapeutic interchange, formulary management and revenue cycle work. He also implemented 340B strategies that increased annual program value by more than $3 million. His clinical and operational leadership contributed to a more than 40% reduction in adverse drug events over three years. He also led an enterprise pharmacy organizational redesign, all while supporting the opening of pharmacies at three of the system’s hospital campuses. Mr. Dugan also serves on national advisory boards and committees, including American Society of Health-System Pharmacists’ next-gen therapeutics steering committee and the Children’s Hospital Association high-cost therapy advisory group.
